Important causes of chronic kidney disease in South Africa.

In hypertensive patients without chronic kidney disease (CKD) the goal is to keep blood pressure (BP) at ≤140/90 mmHg. When CKD ispresent, especially where there is proteinuria of ≥0.5 g/day, the goal is a BP of ≤130/80 mmHg. Lifestyle measures are mandatory, especiallylimitation of salt intake, ingestion of adequate quantities of potassium, and weight control. Patients with stages 4 - 5 CKD must be carefullymonitored for hyperkalaemia and deteriorating kidney function if angiotensin-converting enzyme (ACE) inhibitors or angiotensin IIreceptor blockers (ARBs) are used, especially in patients >60 years of age with diabetes or atherosclerosis. BP should be regularly monitoredand, where possible, home BP-measuring devices are recommended for optimal control.Guidelines on the use of antidiabetic agents in CKD are presented, with the warning that metformin is contraindicated in patients withstages 4 - 5 CKD.There is a wide clinical spectrum of renal disease in the course of HIV infection, including acute kidney injury, electrolyte and acid-basedisturbances, HIV-associated glomerular disease, acute-on-chronic renal disease and side-effects related to the treatment of HIV.

[1]  S. Satchell,et al.  Diabetic nephropathy. , 2012, Clinical medicine.

[2]  L. Szczech,et al.  Development of Proteinuria or Elevated Serum Creatinine and Mortality in HIV-Infected Women , 2003, Journal of acquired immune deficiency syndromes.

[3]  P. Ramdial,et al.  A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. , 2006, Kidney international.

[4]  S. Naicker,et al.  Renal failure in HIV-positive patients—a South African experience , 2013, Clinical kidney journal.

[5]  M. Mendelson,et al.  Renal transplantation between HIV-positive donors and recipients. , 2010, The New England journal of medicine.

[6]  M. Shlipak,et al.  Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  P. Klotman,et al.  Recent progress in HIV-associated nephropathy. , 2002, Journal of the American Society of Nephrology : JASN.

[8]  C. Winkler,et al.  Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans , 2010, Science.

[9]  R. Garrick Highly Active Antiretroviral Therapy and the Kidney: An Update on Antiretroviral Medications for Nephrologists , 2007 .

[10]  L. Szczech,et al.  Immunosuppression, Hepatitis C Infection, and Acute Renal Failure in HIV-Infected Patients , 2006, Journal of acquired immune deficiency syndromes.

[11]  S. Naicker,et al.  HIV and kidney disease in sub-Saharan Africa , 2009, Nature Reviews Nephrology.

[12]  R. Vanholder,et al.  The changing epidemiology of acute renal failure , 2006, Nature Clinical Practice Nephrology.

[13]  J. Simoni,et al.  Continued Smoking Exacerbates but Cessation Ameliorates Progression of Early Type 2 Diabetic Nephropathy , 2008, The American journal of the medical sciences.

[14]  R. Bilous,et al.  KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  J. Palefsky,et al.  Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study1 , 2003, Transplantation.

[16]  J. Bargman,et al.  Survival and morbidity of HIV patients on hemodialysis and peritoneal dialysis: one center’s experience and review of the literature , 2006, International Urology and Nephrology.

[17]  P. Klotman,et al.  Are we missing an epidemic of HIV-associated nephropathy? , 1996, Journal of the American Society of Nephrology : JASN.